In the latest trading session, Pfizer (PFE) closed at $23.72, marking a -2.47% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.72%. Meanwhile, the Dow ...

HSBC downgraded Pfizer Inc. PFE on Monday, citing that the company’s near-term re-rating prospects have weakened despite its ...

Futures are trading higher as we get ready to start the first full week of trading for the third quarter, as traders and ...

A Congressional investigation is looking into whether drug trials in China that involved U.S. companies possibly took place ...

Pfizer Inc. (NYSE:PFE) is one of the best dividend stocks to buy, according to hedge funds. On June 24, the US Food and Drug ...

Zoetis has seen its valuation compress dramatically, now trading at just 12x trailing earnings after a 52% 12-month share ...

Drugmakers are working on a potential new shot to prevent the tick-borne illness. How might it fare in the era of vaccine ...

Knoa Pharma's new CEO, Michael Goettler, will lead a company that was created through Purdue Pharma's bankruptcy process.

Congressional letters sent to the CEOs of Eli Lilly, Pfizer, Merck, BMS and AbbVie this week voicing concerns about the pharmas’ clinical trials in China highlight an ongoing discrepancy in how ...

Nicola met dozens of other women with the same rare tumours and one thing in common - they all took the Depo Provera jab over ...

The U.S. House Select Committee on China has opened investigations into five pharmaceutical companies regarding their clinical trials in China, questioning whether the drugmakers may have aided the ...

Picking a good dividend stock for your portfolio can be challenging, especially when there are many attractive high-yielding ...